AI assistant
NovoCure Ltd — Director's Dealing 2023
Dec 20, 2023
31949_dirs_2023-12-20_a1d27dcf-e062-448e-93f8-9f131214eb2b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2023-07-26
Reporting Person: Giladi Moshe (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 7008.00 | Direct |
| Restricted Share Units | 6496.00 | Direct |
| Restricted Share Units | 2983.00 | Direct |
| Restricted Share Units | 1653.00 | Direct |
| Restricted Share Units | 154.00 | Direct |
| Restricted Share Units | 353.00 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $153.09 | 2031-03-01 | Ordinary Shares (1951.00) | Direct | |
| Stock Options (Right to buy) | $107.73 | 2031-11-01 | Ordinary Shares (831.00) | Direct | |
| Stock Options (Right to buy) | $83.77 | 2032-05-02 | Ordinary Shares (7693.00) | Direct | |
| Stock Options (Right to buy) | $80.59 | 2032-02-29 | Ordinary Shares (4346.00) | Direct | |
| Stock Options (Right to buy) | $77.49 | 2029-11-05 | Ordinary Shares (833.00) | Direct | |
| Stock Options (Right to buy) | $76.97 | 2033-02-27 | Ordinary Shares (10804.00) | Direct | |
| Stock Options (Right to buy) | $69.37 | 2030-03-02 | Ordinary Shares (2779.00) | Direct | |
| Stock Options (Right to buy) | $47.04 | 2029-03-21 | Ordinary Shares (2822.00) | Direct | |
| Stock Options (Right to buy) | $21.15 | 2028-02-26 | Ordinary Shares (3451.00) | Direct | |
| Stock Options (Right to buy) | $7.15 | 2027-02-21 | Ordinary Shares (6875.00) | Direct |
Footnotes
F1: Represents restricted share units that are scheduled to vest in equal installments on February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
F10: Currently exercisable.
F11: Options to buy 10,804 ordinary shares will vest in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
F12: Options to buy 2,779 ordinary shares, 2,085 shares of which are currently exercisable and the remainder will vest on March 3, 2024, subject to the reporting person's continued employment through such date.
F2: Represents restricted share units that are scheduled to vest in equal installments on May 3, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F3: Represents restricted share units that are scheduled to vest in equal installments on March 1, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F4: Represents restricted share units that are scheduled to vest in equal installments on November 2, 2024, subject to the reporting person's continued employment through such date.
F5: Represents restricted share units that are scheduled to vest in equal installments on March 2, 2024, subject to the reporting person's continued employment through such date.
F6: Options to buy 1,951 ordinary shares, 976 shares of which are currently exercisable and the remainder will vest in equal installments on each of March 2, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F7: Options to buy 831 ordinary shares, 416 shares of which are currently exercisable and the remainder will vest in equal installments on each of November 2, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F8: Options to buy 7,693 ordinary shares, 1,924 shares of which are currently exercisable and the remainder will vest in equal installments on each of May 3, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
F9: Options to buy 4,346 ordinary shares, 1,087 shares of which are currently exercisable and the remainder will vest in equal installments on each of March 1, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.